Neue innovative Schrittmachersysteme – Kabellose und subkutane Implantate

Abstract

Conventional transvenous pacemaker and ICD-therapy is associated with significant lead- and pocket-related problems. Leadless pacemaker and subcutaneous ICD (S-ICD) therapies are innovative technologies, that avoid these complications. To date two leadless pacemaker systems have been implanted percutaneously for isolated right ventricular pacing, the Nanostim™ and the Micra™ device. The S-ICD represents an alternative to the transvenous ICD for primary and secondary prevention of sudden cardiac death. New multicomponent leadless pacemakers, as well as the combination of leadless pacemaker and S-ICD, are promising therapeutic options in the future. This review describes the state of the art of leadless pacing and S-ICD-therapy.

Die konventionelle Schrittmachertherapie ist mit einem hohen peri- und postoperativen Risiko behaftet. Daher stellen innovative kabellose Schrittmacher und subkutane ICDs neue Therapieoptionen dar, die diese Risiken deutlich reduzieren können.

Schlüsselwörter

Kabelloser Schrittmacher - Herzschrittmacher - subkutaner ICD - S-ICD - Defibrillator

Key words

leadless pacemaker - pacemaker - subcutanous ICD - S-ICD - defibrillator

• Literatur

• 1 Kusumoto FM, Schoenfeld MH, Wilkoff BL. et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm 2017; 14: e503-e551
• 2 Kiviniemi MS, Pirnes MA, Eranen HJ. et al. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol 1999; 22: 711-720
• 3 Udo EO, Zuithoff NPA, van Hermel NM. et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: The FOLLOWPACE study. Heart Rhythm 2012; 9: 728-735
• 4 Kleemann T, Becker T, Doenges K. et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of > 10 years. Circulation 2007; 115: 2474-2480
• 5 Chew DS, Kuriachan V. Leadless cardiac pacemakers: present and the future. Curr Opin Cardiol 2018; 33: 7-13
• 6 Bardy GH, Smith WM, Hood MA. et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010; 363: 36-44
• 7 Auricchio A, Delnoy PP, Butter C. et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study. Europace 2014; 16: 681-688
• 8 Reddy VY, Knops RE, Sperzel J. et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation 2014; 129: 1466-1471
• 9 Reddy VY, Exner DV, Cantillon DJ. et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med 2015; 373 (12) 1125-1135
• 10 Reynolds D, Duray GZ, Omar R. et al. A leadless intracardiac transcatheter pacing system. N Engl J Med 2016; 374: 533-541
• 11 Duray GZ, Ritter P, El-Chami M. et al. Long-term performance of a transcath-eter pacing system: 12-Month results from the Micra Transcatheter PacingStudy. Heart Rhythm 2017; 14: 702-709
• 12 Reddy VY, Miller MA, Neuzil P. et al. Cardiac resynchronization therapy withwireless left ventricular endocardial pacing: the SELECT-LV study. J Am Coll Cardiol 2017; 69: 2119-2129
• 13 Della Rocca DG, Gianni C, Di Biase L. et al. Leadless pacemakers: State of the art and future perspectives. Card Electrophysiol Clin 2018; 10 (01) 17-29
• 14 Boveda S, Lenarczyk R, Haugaa KH. et al. Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey. Europace 2018; 20: 555-559
• 15 Burke MC, Gold MR, Knight BP. et al. Safety and efficacy of the totally implantable defibrillator: 2-year results from a pooled analysis of the IDE and EFFORTLESS registry. J Am Coll Cardiol 2015; 65: 1605-1615
• 16 Gold MR, Theuns DS, Knight BP. et al. Head-to-head comparison of arrhythmia discrimination performance of subcutaneousand transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol 2012; 23: 359-366
• 17 Priori SG, Blomstrom-Lundqvist C, Mazzanti A. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36: 2793-2867
• 18 Madhavan M, Mulpuru SK, McLeod CJ. et al. Advances and future directions in cardiac pacemakers: part 2 of a 2-part series. J Am Coll Cardiol 2017; 69: 211-235
• 19 Tjong FV, Brouwer TF, Koop B. et al. A 3-month performance of a communicating leadless antitachycardia pacemaker and subcutaneous implantable defibrillator. JACC Clin Electrophysiol 2017; 3: 1487-1498